27 reports of this reaction
2.2% of all ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE reports
#5 most reported adverse reaction
CONSTIPATION is the #5 most commonly reported adverse reaction for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE, manufactured by Rugby Laboratories. There are 27 FDA adverse event reports linking ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE to CONSTIPATION. This represents approximately 2.2% of all 1,232 adverse event reports for this drug.
Patients taking ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE who experience constipation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONSTIPATION is a less commonly reported adverse event for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE, but still significant enough to appear in the safety profile.
In addition to constipation, the following adverse reactions have been reported for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE:
The following drugs have also been linked to constipation in FDA adverse event reports:
CONSTIPATION has been reported as an adverse event in 27 FDA reports for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONSTIPATION accounts for approximately 2.2% of all adverse event reports for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE, making it a notable side effect.
If you experience constipation while taking ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.